Sounds reasonable, until you look at the Silicon Valley experience. Silicon Valley grew like a weed precisely because employees could…
Morning Headlines 8/26/21
Ginger and Headspace Will Merge to Meet Escalating Global Demand for Mental Health Support
Digital mental health and wellbeing companies Ginger and Headspace will merge to form Headspace Health, with Ginger CEO Russell Glass taking on the same role with the combined company.
AccessDX Holdings Acquires 2bPrecise
Allscripts sells its precision medicine software subsidiary 2bPrecise to laboratory diagnostics company AccessDX.
Antidote Health raises $12 million to set up the first virtual HMO in the United States
Antidote Health, a virtual primary and urgent care company serving patients in five states, will use $12 million in seed funding to establish a health maintenance organization for its customers.
We just closed our $2.5m seed round. Here’s what that means.
Rezilient Health raises $2.5 million to launch its hybrid clinic concept for employees in St. Louis.
Bets on Cerner or Veritas Capital (Athena/Centricity) to acquire Allscripts? For above or below 1.5 billion?
They have zero debt and close to $1.5B in annual revenue. And two decades of clinical data. They should go private like Epic or sell for $4B. So I’ll take the over.
Huh I guess my impression was that they lose money on that revenue, even after they have spent several years focused on cost cutting. I’m not an accountant either.
They have the best data business of any EHR. I don’t have a good understanding of their business. Can they separate out the EHR products that are losing customers (Sunrise/Horizon/maybe Touchworks) from the products that are gaining customers (professional/Veradigm/maybe PF?) How close are they to a skeleton crew? etc.